AB 1440 ties employer obligations under Title 3, Section 6728 (medical supervision for workers who handle pesticides) to contracting with a medical supervisor registered with the Office of Environmental Health Hazard Assessment (OEHHA). It also requires laboratories performing cholinesterase testing to submit detailed, monthly electronic reports to the Department of Pesticide Regulation (DPR) in a director-approved format and mandates information sharing among DPR, OEHHA, and the State Department of Public Health for surveillance and case management.
The bill makes the medical supervisor responsible for ensuring that workers and employers receive test results and recommendations within 14 days and for reporting suspected pesticide-related cholinesterase depression to local health officers. OEHHA must operate a registration system for medical supervisors, may set performance requirements, and may provide consultation to medical supervisors and county agricultural commissioners.
The statute also includes a sunset provision and confidentiality rules with narrow public-health exceptions, creating implementation and privacy trade-offs for employers, labs, and public-health agencies.
At a Glance
What It Does
The bill requires employers to contract with OEHHA-registered medical supervisors to meet medical supervision duties and forces laboratories to send monthly, electronic cholinesterase test reports to DPR containing a prescribed set of identifiers, test values, order purpose, and contact information. DPR must share cholinesterase data with OEHHA and the State Department of Public Health for surveillance and investigation.
Who It Affects
California agricultural employers who use cholinesterase medical supervision under Title 3 §6728, clinical laboratories that perform cholinesterase assays, OEHHA as the registrar and consultant, DPR and State Public Health for surveillance, and county agricultural commissioners and local health officers who receive shared data for investigations.
Why It Matters
This creates a routine, lab-driven surveillance stream for cholinesterase depressions tied directly to employer medical-supervision obligations, shifting some detection and reporting from ad hoc clinical practice into a regulated, centralized reporting system — with implications for worker safety, privacy, and compliance costs for employers and labs.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
AB 1440 makes two connected changes to how pesticide-related cholinesterase testing is organized in California. First, it makes contracting with a medical supervisor registered by OEHHA a condition for employers to satisfy the medical supervision responsibilities assigned in Title 3, Section 6728.
That moves oversight of who may act as a medical supervisor from informal arrangements to a registry-based model, with OEHHA able to set performance requirements and deregister supervisors when appropriate.
Second, the bill turns labs into routine reporters. Any laboratory that performs cholinesterase tests ordered by a registered medical supervisor must submit a monthly electronic report to DPR in a director-approved format.
The required report content is granular: numeric IU/mL test results, the purpose of the test (baseline, follow-up, recovery, or clinical evaluation), identifying data for the patient and employer, accession numbers, specimen and reporting dates, and contact details for the ordering medical supervisor and collecting lab. DPR will routinely share this dataset with OEHHA and the State Department of Public Health to support surveillance, case management, and investigations.The medical supervisor who orders a test has two concrete operational duties: note their name and the test purpose on the order, and deliver the test result and any medical recommendations to both the worker and the employer within 14 days of receiving the lab result.
If the supervisor identifies a cholinesterase depression indicating pesticide exposure, they must notify the local health officer under the statutory reporting line. Finally, the statute makes the reported information confidential except for narrow public-health uses and states that OEHHA, DPR, and public health may share data with county agricultural commissioners and local health officers for surveillance, investigation, and remediation.AB 1440 also requires OEHHA to maintain a registry (including deregistration) and to review test results, offering toxicological or medical consultation to supervisors and county commissioners.
The bill instructs DPR and OEHHA to prepare and post a public update on the medical supervision program’s effectiveness and the utility of lab-based reporting. The statute includes a sunset clause that schedules repeal on a fixed future date unless extended, which the bill text presents in a way that requires clarification before implementation.
The Five Things You Need to Know
The bill requires employers relying on Title 3 §6728 medical supervision to contract with a medical supervisor registered with OEHHA.
Laboratories must submit monthly electronic cholinesterase reports to DPR in a director-approved format that include numeric results in IU/mL, accession number, specimen collection and report dates, and whether the test is baseline, follow-up, recovery, or clinical evaluation.
The ordering medical supervisor must ensure the worker and employer receive test results and any recommendations within 14 days of receipt and must report suspected pesticide-related cholinesterase depression to the local health officer.
DPR must share cholinesterase reports with OEHHA and the State Department of Public Health on an ongoing electronic basis to support surveillance, case management, and investigation.
OEHHA must establish a registration/deregistration procedure for medical supervisors, may set reasonable performance requirements, and may provide medical or toxicological consultation to supervisors and county agricultural commissioners.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Employer obligation: contract with OEHHA-registered medical supervisor
This section conditions an employer’s compliance with the medical-supervision duties in Title 3, §6728 on having a contract with a medical supervisor who is registered with OEHHA. Practically, employers who currently rely on in‑house clinicians or ad hoc arrangements must confirm their supervisor appears on OEHHA’s registry or secure a registered supervisor. That creates a gatekeeping function for OEHHA and may require employers to renegotiate service agreements or recruit new clinicians who meet any OEHHA registration criteria.
Mandatory laboratory reporting to DPR; electronic and monthly
Any laboratory that performs cholinesterase tests ordered by a registered medical supervisor must report specified information to DPR at least monthly and in an electronic format approved by DPR’s director. The monthly cadence and director-approved formatting mean DPR will control file layouts and submission methods, which affects lab IT workflows and potentially their billing and data-exchange processes. The subdivision also mandates that DPR share the reports with OEHHA and the State Department of Public Health to meet downstream surveillance obligations.
Required data fields in laboratory reports
The bill lists a detailed data set labs must include: numeric test results in IU/mL; test purpose (baseline, follow-up, recovery, or clinical evaluation); full patient identifiers and a unique identifier (facility ID and insurer/group/provider identifiers); ordering supervisor’s NPI and contact info; collecting lab contact info; specimen accession number; collection and reporting dates; and contact information for the worker and employer where available. That level of granularity is useful for case linkage and trend analysis but raises compliance complexity for labs and potential privacy conflicts with existing health information protections.
Medical supervisor duties: ordering, communication, and reporting
The medical supervisor must record their name and the purpose of the test on the lab order, provide results and any medical recommendations to both the worker and employer within 14 days of receipt, and report workers with cholinesterase depression indicating pesticide exposure to the local health officer. This creates a strict timeline for clinical follow-up and formalizes the supervisor’s role as both clinician and notifier, potentially increasing administrative workload and exposing supervisors to mandatory reporting responsibilities tied to public-health action.
Confidentiality and limited public-health sharing
Reported information is confidential under Section 100330, but DPR, OEHHA, and the State Department of Public Health may share it for surveillance, case management, investigation, environmental remediation, or abatement with the county agricultural commissioner and local health officer. The provision tries to balance worker privacy with the needs of public-health and regulatory agencies, but it also sets up multiple lawful disclosure pathways that entities will need to map against HIPAA and other state privacy laws.
OEHHA registration, review, and consultation role
OEHHA must establish a procedure to register and deregister medical supervisors and can set reasonable performance requirements. OEHHA will review cholinesterase results and may offer medical or toxicological consultation to ordering supervisors and county agricultural commissioners. This builds OEHHA as an operational hub for quality control and expert consultation but also obligates it to develop administrative capacity for registration, recordkeeping, result review, and consultative support.
Program evaluation requirement and sunset clause
The bill directs DPR and OEHHA to prepare and publicly post an update on the medical supervision program’s effectiveness and on the utility of lab-based reporting, with a statutory date referenced in the text. It also includes a sunset provision intended to repeal the section on a future January 1 date unless extended; the draft text contains multiple years which creates drafting ambiguity that implementers will need clarified before operational rollout. Both the evaluation requirement and the sunset mean the program is conceived as potentially temporary or pilot-like unless later made permanent.
This bill is one of many.
Codify tracks hundreds of bills on Agriculture across all five countries.
Explore Agriculture in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Agricultural workers who handle organophosphate or carbamate pesticides — faster, centralized lab reporting and required medical-supervisor follow-up should improve detection of cholinesterase depression and prompt medical and workplace interventions.
- Public-health agencies (OEHHA, State Department of Public Health, county local health officers) — gain routine, standardized data for surveillance, case-finding, and targeted investigations rather than relying solely on voluntary clinical reporting or complaint-driven detection.
- County agricultural commissioners — receive actionable lab-derived information tied to specific workplaces, improving the ability to link clinical findings to field investigations and potential enforcement or remediation.
Who Bears the Cost
- Employers using Title 3 §6728 supervision — must contract with OEHHA‑registered medical supervisors, potentially increasing contracting costs and administrative oversight obligations.
- Clinical laboratories — face new monthly electronic reporting requirements, directory/formatting compliance, and possible IT and staffing costs to extract, de-identify/identify, and transmit detailed data fields in a director-approved format.
- OEHHA and DPR — must staff and operate a registration system, review results, provide consultations, and prepare program effectiveness reports, imposing resource and staffing demands unless funded separately by the statute or budget appropriations.
Key Issues
The Core Tension
The bill balances two legitimate goals — stronger, standardized surveillance and faster worker protections versus protecting individual health information and limiting regulatory and compliance burdens — and it offers no easy compromise: tighter reporting and mandatory registration improves detection and public-health response but increases costs, privacy risks, and administrative demands on employers, labs, and state agencies.
The bill creates useful surveillance infrastructure but raises several implementation challenges. First, the required data set includes both detailed patient identifiers and payer/provider group identifiers; reconciling these fields with HIPAA and state confidentiality rules will require careful legal mapping and likely data-use agreements.
The statute attempts to limit disclosures to public-health and regulatory purposes, but operational guidance will be necessary to define what qualifies as case management, investigation, or remediation and who may access which fields. Second, monthly electronic reporting in a director-approved format centralizes control at DPR but shifts technical burdens to laboratories—smaller or regional labs may need time and funding to comply.
DPR’s choice of format, acceptance protocol, and error-handling policies will materially affect labs’ compliance costs.
Third, OEHHA’s new registry and consultative functions presume a pool of qualified medical supervisors and sufficient OEHHA capacity; if either is lacking, employers may struggle to meet contracting requirements and OEHHA may be unable to provide timely consultations. Finally, the statutory text includes a sunset clause with multiple dates as drafted, creating legal ambiguity about how long these obligations persist; that ambiguity, plus the evaluation requirement, suggests legislators intended a pilot approach but left the operational timeline unclear.
Absent clarity on funding for OEHHA and DPR to cover increased responsibilities, the program risks being under-resourced at exactly the moment agencies are asked to expand surveillance operations.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.